Head-to-head · WeighScore
Next Vial vs Teladoc Health
The verdict
Next Vial takes it — 59.3/100 to 55.9/100.
Next Vial grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Next Vial | Teladoc Health |
|---|---|---|
| WeighScore | 59.3/100 | 55.9/100 |
| Grade | C | C |
| Scorecard rank | #345 | #429 |
| Semaglutide | $250/mo (compounded) | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | 49 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #345 · C
Strengths
- LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
- No membership fees — one all-in price covering consultation, medication, and shipping
- Compounded semaglutide, tirzepatide, and microdose options available
- Free rushed shipping; serves 49 states nationwide
- Board-certified physician oversight with ongoing provider support
Where it loses points
- Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
- Compounded medications are not FDA-approved
- Labs and nutritional coaching not disclosed
- Microdose pricing not published on product page
- Alaska not listed among served states
Graded #429 · C
Strengths
- Dedicated GLP-1 Prescription and Support program for weight management
- Backed by one of the largest virtual care companies in the US
- Partners with 50%-plus of Fortune 500 and 100-plus health plans
- Adds nutrition, coaching and connected device tracking
- Strong clinical credibility and brand trust
Where it loses points
- Distributed mainly via employers and health plans, limited direct cash-pay
- No transparent published monthly price for GLP-1 care
- Specific medications and eligibility vary by plan coverage
- Member experience can depend on the employer's chosen configuration
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.